These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 17307610
1. Severe osteomyelitis of the mandible associated with the use of non-nitrogen-containing bisphosphonate (disodium clodronate): report of a case. Senel FC, Saracoglu Tekin U, Durmus A, Bagis B. J Oral Maxillofac Surg; 2007 Mar; 65(3):562-5. PubMed ID: 17307610 [No Abstract] [Full Text] [Related]
2. Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: Report of 3 cases. Curi MM, Cossolin GS, Koga DH, Araújo SR, Feher O, dos Santos MO, Zardetto C. J Oral Maxillofac Surg; 2007 Feb; 65(2):349-55. PubMed ID: 17236949 [No Abstract] [Full Text] [Related]
3. Bisphosphonate-induced avascular osteonecrosis of the mandible associated with a common thrombophilic mutation in the prothrombin gene. Vairaktaris E, Vassiliou S, Avgoustidis D, Stathopoulos P, Toyoshima T, Yapijakis C. J Oral Maxillofac Surg; 2009 Sep; 67(9):2009-12. PubMed ID: 19686941 [No Abstract] [Full Text] [Related]
5. Necrotic actions of nitrogen-containing bisphosphonates and their inhibition by clodronate, a non-nitrogen-containing bisphosphonate in mice: potential for utilization of clodronate as a combination drug with a nitrogen-containing bisphosphonate. Oizumi T, Yamaguchi K, Funayama H, Kuroishi T, Kawamura H, Sugawara S, Endo Y. Basic Clin Pharmacol Toxicol; 2009 May; 104(5):384-92. PubMed ID: 19413658 [Abstract] [Full Text] [Related]
6. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases. Alons K, Kuijpers SC, de Jong E, van Merkesteyn JP. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb; 107(2):e1-7. PubMed ID: 19071040 [Abstract] [Full Text] [Related]
7. Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]. Harper RP, Fung E. J Oral Maxillofac Surg; 2007 Mar; 65(3):573-80. PubMed ID: 17307613 [No Abstract] [Full Text] [Related]
8. Bone regeneration without bone grafting after resection of a segment of the mandible to treat bisphosphonate-related osteonecrosis of the jaw. Wilde F, Hendricks J, Riese C, Pausch NC, Schramm A, Heufelder M. J Oral Maxillofac Surg; 2011 Oct; 69(10):2657-62. PubMed ID: 21741741 [No Abstract] [Full Text] [Related]
9. Bisphosphonate-related osteonecrosis of the jaws associated with photodynamic therapy. Sardella A, Carrassi A, Tarozzi M, Lodi G. J Oral Maxillofac Surg; 2011 Oct; 69(10):e314-6. PubMed ID: 21939806 [No Abstract] [Full Text] [Related]
10. Bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma. Infante Cossío P, Cabezas Macián A, Pérez Ceballos JL, Palomino Nicas J, Gutiérrez Pérez JL. Med Oral Patol Oral Cir Bucal; 2008 Jan 01; 13(1):E52-7. PubMed ID: 18167482 [Abstract] [Full Text] [Related]
11. Osteonecrosis associated with short-term oral administration of bisphosphonate. Takagi Y, Sumi Y, Harada A. J Prosthet Dent; 2009 May 01; 101(5):289-92. PubMed ID: 19410063 [Abstract] [Full Text] [Related]
12. Bisphosphonate-related osteonecrosis of the jaw combined with jaw metastasis of prostate adenocarcinoma: report of a case. Frei M, Bornstein MM, Schaller B, Reichart PA, Weimann R, Iizuka T. J Oral Maxillofac Surg; 2010 Apr 01; 68(4):863-7. PubMed ID: 20307770 [No Abstract] [Full Text] [Related]
13. The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates. Kraj M, Pogłód R, Maj S, Owczarska K. Acta Pol Pharm; 2006 Apr 01; 63(5):450-2. PubMed ID: 17357613 [No Abstract] [Full Text] [Related]
14. Painful tongue ulcerations in patients with bisphosphonate-associated osteonecrosis of the jaws. Treister NS, Richardson P, Schlossman R, Miller K, Woo SB. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jun 01; 105(6):e1-4. PubMed ID: 18417376 [Abstract] [Full Text] [Related]
15. Oral sodium clodronate induced osteonecrosis of the jaw in a patient with myeloma. Montazeri AH, Erskine JG, McQuaker IG. Eur J Haematol; 2007 Jul 01; 79(1):69-71. PubMed ID: 17598839 [Abstract] [Full Text] [Related]
16. Osteonecrosis of the posterior mandible after implant insertion: a clinical and histological case report. Favia G, Piattelli A, Sportelli P, Capodiferro S, Iezzi G. Clin Implant Dent Relat Res; 2011 Mar 01; 13(1):58-63. PubMed ID: 19681933 [Abstract] [Full Text] [Related]
17. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients. Friedrich RE, Blake FA. Anticancer Res; 2007 Mar 01; 27(4A):1841-5. PubMed ID: 17649782 [Abstract] [Full Text] [Related]
18. Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws. Gallego L, Junquera L. Br J Oral Maxillofac Surg; 2009 Jan 01; 47(1):67-8. PubMed ID: 18639371 [Abstract] [Full Text] [Related]
19. Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity. Lugassy G, Shaham R, Nemets A, Ben-Dor D, Nahlieli O. Am J Med; 2004 Sep 15; 117(6):440-1. PubMed ID: 15380503 [No Abstract] [Full Text] [Related]
20. Pathological fractures in patients caused by bisphosphonate-related osteonecrosis of the jaws: report of 3 cases. Wongchuensoontorn C, Liebehenschel N, Wagner K, Fakler O, Gutwald R, Schmelzeisen R, Sauerbier S. J Oral Maxillofac Surg; 2009 Jun 15; 67(6):1311-6. PubMed ID: 19446222 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]